Get started
KLARIA PHARMA HOLDING ABKLARIA PHARMA HOLDING ABKLARIA PHARMA HOLDING AB

KLARIA PHARMA HOLDING AB

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

KLAR chart


Full chart

KLAR upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪159.96 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.385 SEK
Net income (FY)
‪−47.75 M‬ SEK
Revenue (FY)
‪2.25 M‬ SEK
Shares float
—
Beta (1Y)
4.29

Employees


Employees (FY)
4
Change (1Y)
−1 −20.00%
Revenue / Employee (1Y)
‪562.00 K‬ SEK
Net income / Employee (1Y)
‪−11.94 M‬ SEK

About KLARIA PHARMA HOLDING AB


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Scott Boyer
Website
klaria.com
Headquarters
Uppsala
Founded
2014
ISIN
SE0007280326
FIGI
BBG00B8FRYK7
Klaria Pharma Holding AB engages in the development and commercialization of pharmaceutical products for migraine and cancer-related pain. Its operation is based on a patented drug delivery platform in an alginate-based polymer film. The firm's project portfolio currently includes various pain states, opioid overdoses, cannabinoids, and allergic shock. The company was founded by Scott Boyer and Fredrik Hübinette in 2015 and is headquartered in Uppsala, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

KLAR news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as KLAR.

Frequently Asked Questions


The current price of KLAR is 1.080 SEK — it has decreased by −1.36% in the past 24 hours. Watch KLARIA PHARMA HOLDING AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange KLARIA PHARMA HOLDING AB stocks are traded under the ticker KLAR.
KLAR stock has risen by 5.83% compared to the previous week, the month change is a 6.86% rise, over the last year KLARIA PHARMA HOLDING AB has showed a 500.00% increase.
We've gathered analysts' opinions on KLARIA PHARMA HOLDING AB future price: according to them, KLAR price has a max estimate of 1.80 SEK and a min estimate of 1.80 SEK. Watch KLAR chart and read a more detailed KLARIA PHARMA HOLDING AB stock forecast: see what analysts think of KLARIA PHARMA HOLDING AB and suggest that you do with its stocks.
KLAR reached its all-time high on Jan 22, 2019 with the price of 18.240 SEK, and its all-time low was 0.140 SEK and was reached on Apr 15, 2024. View more price dynamics on KLAR chart.
See other stocks reaching their highest and lowest prices.
KLAR stock is 17.56% volatile and has beta coefficient of 4.29. Track KLARIA PHARMA HOLDING AB stock price on the chart and check out the list of the most volatile stocks — is KLARIA PHARMA HOLDING AB there?
Today KLARIA PHARMA HOLDING AB has the market capitalization of ‪159.96 M‬, it has decreased by −16.67% over the last week.
Yes, you can track KLARIA PHARMA HOLDING AB financials in yearly and quarterly reports right on TradingView.
KLARIA PHARMA HOLDING AB is going to release the next earnings report on May 9, 2025. Keep track of upcoming events with our Earnings Calendar.
KLAR net income for the last quarter is ‪−15.58 M‬ SEK, while the quarter before that showed ‪−7.87 M‬ SEK of net income which accounts for −98.03% change. Track more KLARIA PHARMA HOLDING AB financial stats to get the full picture.
No, KLAR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 4 employees. See our rating of the largest employees — is KLARIA PHARMA HOLDING AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KLARIA PHARMA HOLDING AB EBITDA is ‪−15.32 M‬ SEK, and current EBITDA margin is −892.62%. See more stats in KLARIA PHARMA HOLDING AB financial statements.
Like other stocks, KLAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KLARIA PHARMA HOLDING AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KLARIA PHARMA HOLDING AB technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KLARIA PHARMA HOLDING AB stock shows the neutral signal. See more of KLARIA PHARMA HOLDING AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.